Do you have the same question? Follow this Question
Nov 21, 2024 - 01:31 PM
We’ve provided several answers to questions related to Briviact (brivaracetam) , see some other helpful Q&A related to this product.
Question: What is the significance of Briviact's nearly 100% bioavailability?
Answer: The nearly 100% bioavailability of Briviact signifies that the drug is highly effective in reaching systemic circulation, maximizing its potential to manage partial-onset seizures in patients.
Question: What precautions should be taken when using Briviact?
Answer: Precautions include discussing all medications with your doctor, monitoring for suicidal behavior, avoiding sudden discontinuation, and being cautious with activities requiring alertness, such as driving. These measures ensure safe use and minimize adverse effects.
Question: What is the recommended starting dose for adults taking Briviact?
Answer: For adults 16 years and older, the recommended starting dose for monotherapy or adjunctive treatment is 50 mg twice daily. This dosage helps initiate effective seizure control while allowing room for adjustments based on patient response.
Question: What is the DrugBank ID for Briviact?
Answer: The DrugBank ID for Briviact is DB05541. DrugBank is a comprehensive resource for detailed drug information, supporting research and informing healthcare decisions.
Question: What is the protein binding percentage of Briviact?
Answer: Briviact has a protein binding of less than or equal to 20%. Low protein binding means more of the drug is available to exert its therapeutic effects, which can be beneficial in achieving seizure control.
Question: What is the legal status of Briviact?
Answer: Briviact is available by prescription only (Rx-only). This regulation ensures that it is used under medical supervision, which is important given its potential side effects and interactions with other medications.
